{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T23:31:29Z","timestamp":1772235089889,"version":"3.50.1"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016209","name":"Bilimsel Ara\u015ft\u0131rma Projeleri, Erciyes \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016209","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Autism spectrum disorder (ASD) arises from complex genetic and environmental factors that disrupt neural development during early brain maturation. Erythropoietin (EPO) has been studied for its neuroprotective effects and more recently for its potential to influence neurodevelopment in early postnatal ASD models. However, ASD is not typically diagnosed in humans until 2\u20133 years of age, a stage well beyond early postnatal development. To address this timing gap, we administered darbepoetin alfa, a long-acting EPO analogue, to valproic acid-exposed rats beginning at postnatal day 21 for five consecutive days, and assessed ASD-relevant social and cognitive behaviors. Behavioral assessments using the three-chamber test and Morris Water Maze revealed no significant improvements in ASD-relevant behaviors despite clear systemic activity, as evidenced by substantial hematocrit elevation (~70%). Our findings suggest the therapeutic window for EPO analogues may close before the post-diagnostic period, highlighting a critical translational challenge: interventions effective in early neonatal windows may not retain efficacy at clinically accessible diagnostic stages. The pronounced hematological response further precludes testing whether higher doses could compensate for delayed timing, though non-erythropoietic derivatives may circumvent this limitation in future studies.<\/jats:p>","DOI":"10.1371\/journal.pone.0337294","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T18:24:07Z","timestamp":1764008647000},"page":"e0337294","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic timing limitations of postnatal darbepoetin in a valproic acid rat model of Autism Spectrum Disorder"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4538-7141","authenticated-orcid":true,"given":"\u00d6mer Yusuf","family":"\u0130pek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tu\u011fba","family":"Kirbo\u011fa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ercan","family":"Babur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurcan","family":"Dursun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cem","family":"S\u00fcer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"issue":"1","key":"pone.0337294.ref001","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13229-024-00593-6","article-title":"Systematic review and meta-analysis: multimodal functional and anatomical neural alterations in autism spectrum disorder","volume":"15","author":"Z Guo","year":"2024","journal-title":"Mol Autism"},{"issue":"4","key":"pone.0337294.ref002","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/aur.3069","article-title":"Figurative language processing in autism spectrum disorders: A review","volume":"17","author":"S Lampri","year":"2024","journal-title":"Autism Res"},{"issue":"1","key":"pone.0337294.ref003","doi-asserted-by":"crossref","first-page":"3","DOI":"10.24171\/j.phrp.2024.0286","article-title":"The global prevalence of autism spectrum disorder in children: a systematic review and meta-analysis","volume":"16","author":"A Issac","year":"2025","journal-title":"Osong Public Health Res Perspect"},{"issue":"3","key":"pone.0337294.ref004","doi-asserted-by":"crossref","first-page":"281","DOI":"10.31887\/DCNS.2012.14.3\/pchaste","article-title":"Autism risk factors: genes, environment, and gene-environment interactions","volume":"14","author":"P Chaste","year":"2012","journal-title":"Dialogues Clin Neurosci"},{"issue":"7","key":"pone.0337294.ref005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/jmg.37.7.489","article-title":"A clinical study of 57 children with fetal anticonvulsant syndromes","volume":"37","author":"SJ Moore","year":"2000","journal-title":"J Med Genet"},{"key":"pone.0337294.ref006","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.seizure.2025.05.003","article-title":"Association of prenatal exposure to antiseizure medication with risk of autism: a systematic review and meta-analysis","volume":"130","author":"IC Amaral de Lara","year":"2025","journal-title":"Seizure"},{"issue":"1","key":"pone.0337294.ref007","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12929-022-00835-w","article-title":"Generational synaptic functions of GABAA receptor \u03b23 subunit deteriorations in an animal model of social deficit","volume":"29","author":"M-C Chu","year":"2022","journal-title":"J Biomed Sci"},{"issue":"2","key":"pone.0337294.ref008","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2174\/1570159X22666231003121513","article-title":"Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder","volume":"22","author":"D Zarate-Lopez","year":"2024","journal-title":"Curr Neuropharmacol"},{"issue":"18","key":"pone.0337294.ref009","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1111\/bph.14435","article-title":"Sex-specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling","volume":"175","author":"F Melancia","year":"2018","journal-title":"Br J Pharmacol"},{"key":"pone.0337294.ref010","doi-asserted-by":"crossref","first-page":"869792","DOI":"10.3389\/fnbeh.2022.869792","article-title":"Sex Differences in Spatial Learning and Memory in Valproic Acid Rat Model of Autism: Possible Beneficial Role of Exercise Interventions","volume":"16","author":"R Ghahremani","year":"2022","journal-title":"Front Behav Neurosci"},{"issue":"6847","key":"pone.0337294.ref011","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/35088074","article-title":"Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades","volume":"412","author":"M Digicaylioglu","year":"2001","journal-title":"Nature"},{"issue":"6","key":"pone.0337294.ref012","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20021067","article-title":"Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis","volume":"198","author":"P Villa","year":"2003","journal-title":"J Exp Med"},{"issue":"11","key":"pone.0337294.ref013","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41583-021-00507-y","article-title":"Mechanisms governing activity-dependent synaptic pruning in the developing mammalian CNS","volume":"22","author":"TE Faust","year":"2021","journal-title":"Nat Rev Neurosci"},{"issue":"12","key":"pone.0337294.ref014","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1007\/s12264-024-01248-5","article-title":"Microglial EPOR Contribute to Sevoflurane-induced Developmental Fine Motor Deficits Through Synaptic Pruning in Mice","volume":"40","author":"D He","year":"2024","journal-title":"Neurosci Bull"},{"key":"pone.0337294.ref015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bbi.2022.12.001","article-title":"Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD)","volume":"108","author":"HK Hughes","year":"2023","journal-title":"Brain Behav Immun"},{"key":"pone.0337294.ref016","doi-asserted-by":"crossref","first-page":"122102","DOI":"10.1016\/j.lfs.2023.122102","article-title":"EPO prevents neuroinflammation and relieves depression via JAK\/STAT signaling","volume":"333","author":"Y Luo","year":"2023","journal-title":"Life Sci"},{"issue":"1","key":"pone.0337294.ref017","doi-asserted-by":"crossref","DOI":"10.1002\/dev.22353","article-title":"The effects of postnatal erythropoietin and nano-erythropoietin on behavioral alterations by mediating K-Cl co-transporter 2 in the valproic acid-induced rat model of autism","volume":"65","author":"S Haratizadeh","year":"2023","journal-title":"Dev Psychobiol"},{"issue":"1","key":"pone.0337294.ref018","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-019-0138-4","article-title":"Autism spectrum disorder","volume":"6","author":"C Lord","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"pone.0337294.ref019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.04.001","article-title":"Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species","author":"BD Semple","year":"2013","journal-title":"Prog Neurobiol"},{"issue":"8","key":"pone.0337294.ref020","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1177\/01926233211046933","article-title":"Comparative Milestones in Rodent and Human Postnatal Central Nervous System Development","volume":"49","author":"CJ Zeiss","year":"2021","journal-title":"Toxicol Pathol"},{"issue":"1","key":"pone.0337294.ref021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2006.09.041","article-title":"Darbepoetin alfa (Aranesp) improves recognition memory in adult rats that have sustained bilateral ventral hippocampal lesions as neonates or young adults","volume":"144","author":"SE Hori","year":"2007","journal-title":"Neuroscience"},{"issue":"2","key":"pone.0337294.ref022","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MOP.0000000000000077","article-title":"Neuroprotective effects of erythropoiesis-stimulating agents in term and preterm neonates","volume":"26","author":"AM Messier","year":"2014","journal-title":"Curr Opin Pediatr"},{"issue":"4","key":"pone.0337294.ref023","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0301-472X(03)00006-7","article-title":"Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin","volume":"31","author":"JC Egrie","year":"2003","journal-title":"Exp Hematol"},{"issue":"12","key":"pone.0337294.ref024","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/ndt\/15.12.2014","article-title":"The efficacy of once weekly compared with two or three times weekly subcutaneous epoetin beta: results from a randomized controlled multicentre trial. Swedish Study Group","volume":"15","author":"LG Weiss","year":"2000","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"pone.0337294.ref025","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/ajkd.2002.33919","article-title":"Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients","volume":"40","author":"AR Nissenson","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"pone.0337294.ref026","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/ndt\/gfm579","article-title":"Darbepoetin alpha in lower-than-equimolar doses maintains haemoglobin levels in stable haemodialysis patients converting from epoetin alpha\/beta","volume":"23","author":"HA Bock","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"pone.0337294.ref027","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1124\/jpet.110.176602","article-title":"Improved cerebrovascular function and reduced histological damage with darbepoietin alfa administration after cortical impact injury in rats","volume":"337","author":"L Cherian","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"pone.0337294.ref028","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1161\/01.STR.0000132196.49028.a4","article-title":"Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats","volume":"35","author":"L Wang","year":"2004","journal-title":"Stroke"},{"issue":"4","key":"pone.0337294.ref029","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1203\/pdr.0b013e3180332cec","article-title":"A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats","volume":"61","author":"BA Kellert","year":"2007","journal-title":"Pediatr Res"},{"key":"pone.0337294.ref030","doi-asserted-by":"crossref","first-page":"113449","DOI":"10.1016\/j.bbr.2021.113449","article-title":"Examining the impact of neuroimmune dysregulation on social behavior of male and female juvenile rats","volume":"415","author":"A Turano","year":"2021","journal-title":"Behav Brain Res"},{"issue":"2","key":"pone.0337294.ref031","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s13311-023-01360-w","article-title":"Memantine\/Aripiprazole Combination Alleviates Cognitive Dysfunction in Valproic Acid Rat Model of Autism: Hippocampal CREB\/BDNF Signaling and Glutamate Homeostasis","volume":"20","author":"SM Zohny","year":"2023","journal-title":"Neurotherapeutics"},{"issue":"3","key":"pone.0337294.ref032","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0: fundamental algorithms for scientific computing in Python","volume":"17","author":"P Virtanen","year":"2020","journal-title":"Nat Methods"},{"issue":"31","key":"pone.0337294.ref033","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.21105\/joss.01026","article-title":"Pingouin: statistics in Python","volume":"3","author":"R Vallat","year":"2018","journal-title":"JOSS"},{"key":"pone.0337294.ref034","author":"S Seabold","year":"2010","journal-title":"Statsmodels: Econometric and statistical modeling with python"},{"key":"pone.0337294.ref035","volume-title":"Pandas","author":"The pandas development team","year":"2020"},{"issue":"7825","key":"pone.0337294.ref036","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","article-title":"Array programming with NumPy","volume":"585","author":"CR Harris","year":"2020","journal-title":"Nature"},{"issue":"60","key":"pone.0337294.ref037","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.21105\/joss.03021","article-title":"seaborn: statistical data visualization","volume":"6","author":"M Waskom","year":"2021","journal-title":"JOSS"},{"issue":"3","key":"pone.0337294.ref038","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1109\/MCSE.2007.55","article-title":"Matplotlib: A 2D Graphics Environment","volume":"9","author":"JD Hunter","year":"2007","journal-title":"Comput Sci Eng"},{"key":"pone.0337294.ref039","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","article-title":"The valproic acid-induced rodent model of autism","volume":"299","author":"C Nicolini","year":"2018","journal-title":"Exp Neurol"},{"key":"pone.0337294.ref040","doi-asserted-by":"crossref","first-page":"1430267","DOI":"10.3389\/fnbeh.2024.1430267","article-title":"Impairments of social interaction in a valproic acid model in mice","volume":"18","author":"M Ukezono","year":"2024","journal-title":"Front Behav Neurosci"},{"issue":"3","key":"pone.0337294.ref041","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/jeab.760","article-title":"Reinforced behavioral variability in the valproate rat model of autism spectrum disorder","volume":"117","author":"A Galizio","year":"2022","journal-title":"J Exp Anal Behav"},{"issue":"1","key":"pone.0337294.ref042","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41398-021-01458-9","article-title":"Exploratory drive, fear, and anxiety are dissociable and independent components in foraging mice","volume":"11","author":"DE Heinz","year":"2021","journal-title":"Transl Psychiatry"},{"issue":"2","key":"pone.0337294.ref043","article-title":"Identifying iNOS and glycogen as biomarkers for degenerated cerebellar purkinje cells in autism spectrum disorder: Protective effects of erythropoietin and zinc sulfate","volume":"20","author":"AM Al-Garni","year":"2025","journal-title":"PLoS One"},{"issue":"5","key":"pone.0337294.ref044","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1267\/ahc.23-00027","article-title":"Beneficial Effect of Erythropoietin on Ameliorating Propionic Acid-Induced Autistic-Like Features in Young Rats","volume":"56","author":"S A Hosny","year":"2023","journal-title":"Acta Histochem Cytochem"},{"key":"pone.0337294.ref045","doi-asserted-by":"crossref","first-page":"113400","DOI":"10.1016\/j.jpeds.2023.113400","article-title":"Safety of High Dose Erythropoietin Used with Therapeutic Hypothermia as Treatment for Newborn Hypoxic-Ischemic Encephalopathy: Secondary Analysis of the HEAL Randomized Controlled Trial","volume":"258","author":"SE Juul","year":"2023","journal-title":"J Pediatr"},{"issue":"1","key":"pone.0337294.ref046","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/neurosci6010025","article-title":"Carbamoylated Erythropoietin Rescues Autism-Relevant Social Deficits in BALB\/cJ Mice","volume":"6","author":"AL Street","year":"2025","journal-title":"NeuroSci"},{"key":"pone.0337294.ref047","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bbr.2012.08.051","article-title":"Development of home cage social behaviors in BALB\/cJ vs. C57BL\/6J mice","volume":"237","author":"AH Fairless","year":"2013","journal-title":"Behav Brain Res"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0337294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T18:24:15Z","timestamp":1764008655000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0337294"}},"subtitle":[],"editor":[{"given":"Anna-Leena","family":"Sir\u00e9n","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0337294","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]}}}